
Anal Cancer 2025 UPDATE
Two Onc Docs
00:00
PODIUM-303 Trial Results Summary
The hosts summarize PFS, OS trends, response rates, and crossover issues from the randomized phase III trial.
Play episode from 07:58
Transcript

The hosts summarize PFS, OS trends, response rates, and crossover issues from the randomized phase III trial.